Navigation Links
Researchers & Department of Defense Question Multiple Vaccine Administration
Date:12/4/2008

SafeMinds Asks, "Is Mercury a Common Factor?"

WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ -- Two new reports announced last week call into question the safety of the Centers for Disease Control (CDC) decade's old policy of routinely administering multiple vaccines concurrently.

Mitochondrial Disease in Autism Spectrum Disorder Patients, published last week in PLOS One by investigators from the Cleveland Clinic, Johns Hopkins Kennedy Krieger Institute and Massachusetts General Hospital concluded that disturbance in mitochondria (energy production cells) is an underlying mechanism in a subset of individuals with autism. "There might be no difference between the inflammatory or catabolic stress of vaccinations and that of common childhood diseases" they said, and "large, population-based studies will be needed to identify a possible relationship of vaccination with autistic regression in persons with mitochondrial cytopathies."

In a November 26th response to Congresswoman Carolyn Maloney concerning adverse vaccine events, Colonel Renata Engler of the DOD Vaccine Healthcare Center commented on their collaboration with the CDC, "We have preliminary findings from one of our many on-going research studies that suggest a relationship between adverse events and multiple vaccinations exist." She added, "The recommendation for more research on subpopulation risk factors in relation to multiple vaccine combinations has been included in the Institute of Medicine (IOM) Report on Multiple Vaccines."

Regarding findings by Elliott and colleagues in August, the United Mitochondrial Disease Foundation stated that mitochondrial disorder is likely to be at the core of many health conditions including autism. These latest findings provide additional evidence that the link between autism and mitochondrial disorders is not "rare," as government officials characterized it after the Poling family was recently compensated for their daughter's vaccine injury.

SafeMinds Vice President Lyn Redwood stated, "Research clearly demonstrates that mercury in vaccines causes mitochondrial damage, yet mercury-containing vaccines continue to be administered to infants and pregnant women despite the IOM's recommendation that these populations not be exposed." SafeMinds believes the government should initiate a comprehensive study of vaccinated/unvaccinated populations examining all health outcomes, vaccine components and synergistic interactions.

Environmental mercury exposure has also been linked to mental retardation, Attention Deficit Disorder and autism. SafeMinds President Theresa Wrangham added, "Mercury in all forms is neurotoxic and is increasingly impacting public health. Congressional action is needed to shift industry from its use in medicine, utilities and consumer products."

View mercury/mitochondrial research at

www.safeminds.org/research/science-autism-mitochondria-mercury.html


'/>"/>
SOURCE SafeMinds
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel of ... of proceeds to two local organizations: North Chicago Animal Control and Friends and Our ... a team of authorized and trained volunteers who support rescued animals held in the ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... Dallas, Texas, is condemning "scam operations" carried out by unethical locksmith companies and ... scam operations to a halt. According to Texas Premier Locksmith, these fraudulent locksmith ...
(Date:12/7/2016)... CA (PRWEB) , ... December 07, 2016 , ... The ... the holidays and winter seasons. One major study analyzing heart attacks among 138,602 ... to August of a given year. We would all agree of course–no time of ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 2016 BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s ... achieved through user experience. , BOC Global Events & Training Group is a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen ... Program at Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years ... three acupuncturists to help patients realize their family building goals. Acupuncture helps ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- KEY FINDINGS Patient warming and ... loss of blood during surgeries, lowering the risks ... after surgeries, and decreasing risks of SSIs. The ... warming system, surface warming systems, and intravascular warming ... at hospitals thus, lowering the healthcare costs by ...
(Date:12/7/2016)... 7, 2016 Research and Markets has announced ... User - Global Forecast to 2021" report to their offering. ... , , ... by 2021, growing at a CAGR of 7.3% during the forecast period ... prevalence of cancer and rapidly increasing geriatric population across the globe are ...
(Date:12/7/2016)... Dec. 7, 2016 DelveInsight,s, "Janus ... provides in depth insights on the pipeline ... Janus Kinase 3 (JAK3) Inhibitors. The DelveInsight,s ... stages of development including Discovery, Pre-clinical, IND, ... Preregistration. Report covers the product clinical trials ...
Breaking Medicine Technology: